MOLECULAR INEQUALITY IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER (NSCLC) AND IMPLICATIONS FOR CLINICAL TRIALS

被引：0
|
作者：
Naidoo, Jarushka [1 ]
Noonan, Sinead [2 ]
Teo, Min Yuen [3 ]
Rho, Young Soo [1 ]
Clince, Janet [1 ]
Gately, Kathy [4 ]
O'Grady, Tony [5 ]
Kaye, Elaine [5 ]
Calvert, Paula [6 ]
Morris, Patrick G. [7 ]
O'Brien, Cathal [4 ]
O'Byrne, Kenneth [8 ]
Breathnach, Oscar S. [1 ]
机构：
[1] Beaumont Hosp, Dublin, Ireland
[2] St James Hosp, Dublin, Ireland
[3] Inc Natl Childrens Hosp, Adelaide & Meath Hosp, Dublin 24, Ireland
[4] Univ Dublin Trinity Coll, Dublin 2, Ireland
[5] Beaumont Hosp, Dublin, Ireland
[6] Waterford Reg Hosp, Waterford, Ireland
[7] Hermitage Clin, Dublin, Ireland
[8] Princess Alexandra Hosp, Woolloongabba, Qld, Australia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
Treatment; non-small cell lung cancer; Cinical Trials; Inequality;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.11-042
引用
收藏
页码：S1208 / S1208
页数：1
相关论文
共 50 条
  • [41] A review of vaccine clinical trials for non-small cell lung cancer
    Nemunaitis, J.
    Nemunaitis, J.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (01) : 89 - 102
  • [42] Analysis of outcomes and brain metastases (BM) of molecular selected non-small cell lung cancer (NSCLC) patients included in clinical trials
    Cedres, S.
    Pardo Aranda, N.
    Martinez de Castro, A.
    Navarro Mendivil, A.
    Martinez Marti, A.
    Ortiz, C.
    Racca, F.
    Vilaro, M.
    Carbonell, L.
    Piera, A.
    de la Fuente, I.
    Felip, E.
    ANNALS OF ONCOLOGY, 2016, 27
  • [43] Transformation of Non-Small Cell Lung Cancer (NSCLC) to Small Cell Lung Cancer (SCLC), Mechanism of Treatment Resistance?
    Hamedi, Z.
    Kamboj, S.
    Kumar, S.
    Jiwani, R. A.
    Sharma, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [44] Accuracy of Clinical Stage in Resectable Non-small Cell Lung Cancer (NSCLC)
    Gwon, H. R.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S520 - S521
  • [45] Patients with advanced non-small cell lung cancer (NSCLC): Are research biopsies a barrier to participation in clinical trials?
    Lim, Charles Henry
    Sung, Mike
    Nouriany, Nazanin Ziapour
    Sawczak, Magdalena
    Paul, Tuhina
    Perera-Low, Nicole
    Feld, Ronald
    Liu, Geoffrey
    Shepherd, Frances A.
    Leighl, Natasha B.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [46] Molecular treatment stratification of non-small cell lung cancer
    Lang, Susanne M.
    Rachow, Tobias
    ONKOLOGE, 2020, 26 (08): : 727 - 735
  • [47] Clinical Upstaging of Non-Small Cell Lung Cancer That Extends Across the Fissure: Implications for Non-Small Cell Lung Cancer Staging
    Joshi, Vijay
    McShane, James
    Page, Richard
    Carr, Martyn
    Mediratta, Neeraj
    Shackcloth, Michael
    Poullis, Michael
    ANNALS OF THORACIC SURGERY, 2011, 91 (02): : 350 - 354
  • [48] Update on antiangiogenic treatment of advanced non-small cell lung cancer (NSCLC)
    Schmid-Bindert, Gerald
    TARGETED ONCOLOGY, 2013, 8 (01) : 15 - 26
  • [49] Adjuvant chemotherapy and radiotherapy in the treatment of non-small cell lung cancer (NSCLC)
    Zaric, Bojan
    Stojsic, Vladimir
    Tepavac, Aleksandar
    Sarcev, Tatjana
    Zarogoulidis, Paul
    Darwiche, Kaid
    Tsakiridis, Kosmas
    Karapantzos, Ilias
    Kesisis, Georgios
    Kougioumtzi, Ioanna
    Katsikogiannis, Nikolaos
    Machairiotis, Nikolaos
    Stylianaki, Aikaterini
    Foroulis, Christophoros N.
    Zarogoulidis, Konstantinos
    Perin, Branislav
    JOURNAL OF THORACIC DISEASE, 2013, 5 : S371 - S377
  • [50] Economic evaluation of bevacizumab in the treatment of non-small cell lung cancer (NSCLC)
    Chien, Chun-Ru
    Shih, Ya-Chen Tina
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2012, 4 : 201 - 208
12345